NCT05923593

Tolerance and Safety of an Oral Nutritional Supplement (Adolescent Cohort)

Completed NA Last updated 18 October 2023

What this trial tests

NA trial testing MAG oil oral nutritional supplement (ONS) in Healthy Volunteers in 12 participants. Completed in 30 August 2023.

Timeline

20 March 2023

Primary endpoint
15 June 2023

30 August 2023

Quick facts

Lead sponsor	Société des Produits Nestlé (SPN)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	12
Start date	20 March 2023
Primary completion	15 June 2023
Estimated completion	30 August 2023
Sites	1 location across Switzerland

Drugs / interventions tested

• MAG oil oral nutritional supplement (ONS)

Conditions studied

• Healthy Volunteers — all drugs for Healthy Volunteers →

Sponsor

Société des Produits Nestlé (SPN) — full company profile →

Who can join

Adults 12 to 17, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an open label, non-randomized, interventional, single arm study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Safety and tolerability of Monoacylglycerol-rich oil as a novel predigested dietary fat source of an enteral formula in healthy adults and adolescents: Two single-arm, open-label studies.
   Zemrani B, Krattinger LF, Giuffrida F, Corthésy J, et al · · 2025 · PMID 39681164 · DOI 10.1016/j.clnesp.2024.12.014